|
|
News Breaks | | | | October 15, 2012 | | 08:04 EDT |  | CTSH | Cognizant should be bought on any weakness, says RW Baird
Baird said Cognizant (CTSH) should be bought on any weakness caused by announced less than expected Q2 results from Infosys. The firm expects mild upside to consensus on revenues when the company reports Q3 results. Shares remain Outperform rated with a $78 price target. | |
|
News For CTSH From The Last 14 Days Check below for free stories on CTSH the last two weeks. |
|
|
| June 5, 2013 | | 11:25 EDT |  | CTSH | Cognizant management to meet with Oppenheimer
 Subscribe for More Information | |
|
|
|
|
|
|
